Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REPROS THERAPEUTICS INC. (RPRX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16Mar-31-16Dec-31-15
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Cash Flows from Operating Activities          
Net loss  -13.7-16.3-18.3-17.3-19.6-22.0-25.5-29.2
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Depreciation  0.00.00.00.00.00.00.00.0
    Noncash stock-based compensation  1.11.51.81.92.32.73.23.7
    Change in fair value of warrant liability  -0.10.2      
    Increase in prepaid expenses and other current assets  0.00.00.00.00.20.20.30.1
    Increase (decrease) in accounts payable and accrued expenses  1.01.41.6-0.3-0.2-0.60.20.0
        Net cash used in operating activities  -11.6-13.3-14.9-15.6-17.3-19.6-21.8-25.3
   
Cash Flows from Investing Activities          
   
Cash Flows from Financing Activities          
Proceeds from exercise of stock warrants   0.0      
    Net cash provided by financing activities   6.43.92.91.6   
    Net decrease in cash, cash equivalents and restricted cash  -6.9-6.9-11.0-12.7-15.7-19.6-21.8-25.2
   
Noncash transactions:          
    Settlement of warrant liability due to cashless warrant exercises  -0.6       

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy